BEVERLY NELSON: Open Payments
NPI 1730619891 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,121 in 44 payments from 17 companies in 2025. Trend: 2023 $1,836 · 2024 $1,728 · 2025 $1,121
Food & beverage: $1,121
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $285 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $229 |
| Eisai Inc. | 4 | $108 |
| Dexcom, Inc. | 1 | $90 |
| ABBVIE INC. | 3 | $52 |
| Lilly USA, LLC | 2 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Exact Sciences Corporation | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
Products named: Kerendia, BREZTRI, FARXIGA, Leqembi, Dexcom G6 Transmitter, JARDIANCE, AIRSUPRA, RECORLEV.
Industry payments across FL — which companies pay providers there.
